Trials / Recruiting

RecruitingNCT05417971

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

A Phase II Trial of Reduced Intensity Fludarabine and Total Body Irradiation-Based Conditioning Prior to Haplo-Identical Transplantation for Patients With Hematologic Malignancies

Status: Recruiting
Phase: —
Study type: Observational
Enrollment: 20 (estimated)

Sponsor: Northside Hospital, Inc. · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This trial will evaluate the safety and efficacy of RIC HIDT transplant protocol following fludarabine and intermediate-dose TBI 800 cGy utilizing PBSC as the stem cell source.

Conditions

Hematologic Malignancy

Interventions

Type	Name	Description
OTHER	Fludarabine	Reduced-intensity fludarabine with intermediate-dose TBI

Timeline

Start date: 2022-08-29
Primary completion: 2026-07-31
Completion: 2026-12-31
First posted: 2022-06-14
Last updated: 2026-04-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05417971. Inclusion in this directory is not an endorsement.